Recitals Of Monsanto's Roundup MDL Lawsuits
Recitals Of Monsanto's Roundup MDL Lawsuits

Introduction
Bayer is facing a rise in the number of Roundup lawsuits following a series of court losses. One of the latest allegations was filed on Monday, in Kansas federal court, by Perry L. Walters and his wife Laura against Bayer’s Monsanto.
According to a pretrial order issued on May 21, U.S. District Judge Vince Chhabria proposed a plan for returning cases back to their home districts for trial, specifying that the parties should be prepared to discuss the process during a case management conference on May 22. He also indicated that he would decide all case-specific summary judgment and Daubert motions that have previously not addressed, so that all the different U.S. District Courts nationwide will only be left with resolving other pretrial motions, including a motion in limine to bifurcate any other challenge to the admissibility of evidence.
Meanwhile, on May 22, a California federal judge appointed former Sept. 11th Victim Compensation Fund special master Kenneth Feinberg to help mediate a deal in multidistrict litigation involving Monsanto's Roundup. Feinberg recently helped Fiat Chrysler Automobiles NV, auto parts maker Robert Bosch GmbH and consumers with a $307 million settlement, along with an additional $66 million for plaintiffs' attorneys.
Around 13,400 lawsuits are pending in the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California which is overlooked by U.S. District Judge Vince Chhabria.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…